Ciao, Baby

"Dear Andrea, I’m sorry to tell you this. Mark passed away last week. He was killed in a car accident. I’m Jeff, I was his friend. Dear Andrea, I would like to suggest that you stick to your plan and come here anyway..."

If you could go back, what would you say to the one you loved? When fates collide, a new story begins.

I know nothing about this film, never heard of it before, but it looks like it could be sweet. Here is a trailer for it.

Apple to remove copy-protection from iTunes and make pricing more flexible

Apple Inc. closed its final appearance at the Macworld trade show in San Francisco on Tuesday by cutting the price of some songs in its market-leading iTunes online store to as little as 69 cents and disclosing that soon every track will be available without copy protection.

Apple offered the record labels that flexibility on pricing as it got them to agree to sell all songs free of "digital rights management" (DRM) technology that limits people's ability to copy songs or move them to multiple computers. By the end of this quarter, Apple said, all 10 million songs in its library will be available without DRM.

While iTunes is the most popular digital music store, others have been faster to offer songs without copy protection. Amazon.com Inc. started selling DRM-free music in 2007 and swayed all the major labels to sign on in less than a year.

Even afterward, there is something you can do.

IMAGE: Mexican campaign against discrimination toward HIV carriers
http://blog.uncovering.org/en/archives/2007/03/against_the_discrimination_of_hiv_carriers.html

Following from the previous item about PRE-exposure drugs, here is a discussion of a treatment that is already available to people who might have just been exposed to HIV.

Gay men may not be accessing HIV post-exposure prophylaxis (PEP) in situations when its use would be warranted, a study published in the online edition of Sexually Transmitted Infections suggests.

Investigators in Brighton conducted interviews with 15 gay men who were currently taking, or had recently completed, a course of post-exposure prophylaxis after unprotected anal intercourse. They found that prior to accessing this treatment, the men generally had a poor understanding of what post-exposure prophylaxis involved.

Post-exposure prophylaxis (a short course of treatment with antiretroviral drugs after possible exposure to HIV) is becoming increasing available for individuals reporting sexual risk behaviour. The number of gay men presenting for such treatment has increased following targeted advertising campaigns and the publication of professional guidelines.

There is robust evidence that post-exposure prophylaxis can prevent infection with HIV. But there have been reports of HIV infection despite its use following possible sexual exposure to the virus. In many instances these infections can be attributed to ongoing sexual risk behaviour.